Garrison Bradford & Associates Inc Codexis, Inc. Transaction History

Garrison Bradford & Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$4.26 - $6.84 $53,250 - $85,500	-12,500 Reduced 55.56%	10,000 $47,000
Q3 2022 Nov 03, 2022	BUY	$6.06 - $12.86 $12,120 - $25,720	2,000 Added 9.76%	22,500 $136,000
Q2 2022 Aug 23, 2022	BUY	$8.35 - $21.89 $71,008 - $186,152	8,504 Added 70.89%	20,500 $214,000
Q2 2021 Aug 09, 2021	BUY	$17.48 - $25.46 $8,670 - $12,628	496 Added 4.31%	11,996 $272,000
Q1 2020 Apr 28, 2020	SELL	$8.78 - $18.6 $3,073 - $6,510	-350 Reduced 2.95%	11,500 $128,000
Q4 2019 Feb 10, 2020	BUY	$13.12 - $17.06 $155,472 - $202,160	11,850 New	11,850 $189,000
Q2 2019 Aug 05, 2019	SELL	$17.0 - $21.88 $229,500 - $295,380	-13,500 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$15.53 - $22.15 $209,655 - $299,025	13,500 New	13,500 $277,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $184M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Garrison Bradford & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Garrison Bradford & Associates Inc with notifications on news.